After surgical or endovascular revascularization, some ischemic lesions will not heal, while some others will heal at a variable period of time from the intervention, indicating a multifactorial interaction between local and systematic “wound healing–promoting” factors. Our objective was to identify predictors of wound healing following revascularization for chronic limb-threatening ischemia (CLTI).
Methods:
A literature review was performed to identify published research concerning clinical, biochemical, and noninvasive methods as predictors of wound healing time and wound-free period after surgical and endovascular revascularization for CLTI.
Results:
Our review indicated that potential predictors included local wound factors, wound depth, patient’s comorbidities, medications, smoking and alcohol abuse, poor vessel runoff, and direct versus indirect revascularization. Among the clinical biomarkers, platelet-derived growth factor, transforming growth factor β, basic fibroblast growth factor, tumor necrosis factor α, interleukin (IL) 1, and IL-6 have been proposed as potential predictors. Furthermore, the potential of noninvasive microcirculation assessment to predict proper wound healing has been the topic of extensive investigation. Among the novel methods, transcutaneous measurement of oxygen partial pressure, skin perfusion pressure, oxygen-to-see method, indocyanine green fluorescence imaging, and multispectral optoacoustic tomography have shown promising results.
Conclusions:
The risk factor profile of an ischemic lesion in the lower extremities with a delayed/failed healing response, following a successful revascularization, is not fully clarified. Although many predictors have been assessed so far, further research needs to be done to identify the optimal clinical and biochemical indices and the noninvasive technique assessing the microcirculation that is associated with complete wound healing.
FarberA. Chronic limb-threatening ischemia. N Engl J Med. 2018;379(2):171–180.
2.
HoffmannUSchulteKLHeidrichHRiegerHSchellongS. Complete ulcer healing as primary endpoint in studies on critical limb ischemia? A critical reappraisal. Eur J Vasc Endovasc Surg. 2007;33(3):311–316; discussion 7-8.
3.
HallidayABaxJJ. The 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55(3):301–302.
4.
SoderstromMArvelaEAlbackAAhoPSLepantaloM. Healing of ischaemic tissue lesions after infrainguinal bypass surgery for critical leg ischaemia. Eur J Vasc Endovasc Surg. 2008;36(1):90–95.
5.
GreavesNSAshcroftKJBaguneidMBayatA. Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing. J Dermatol Sci. 2013;72(3):206–217.
6.
Thomas HessC. Checklist for factors affecting wound healing. Adv Skin Wound Care. 2011;24(4):192.
7.
LiuSHeCZCaiYTet al.Evaluation of negative-pressure wound therapy for patients with diabetic foot ulcers: systematic review and meta-analysis. Ther Clin Risk Manag. 2017;13:533–544.
8.
LiuZDumvilleJCHinchliffeRJet al.Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database Syst Rev. 2018;10:CD010318.
9.
AbbasMUckayILipskyBA. In diabetic foot infections antibiotics are to treat infection, not to heal wounds. Expert Opin Pharmacother. 2015;16(6):821–832.
10.
BarwellNDDeversMCKennonBet al.Diabetic foot infection: antibiotic therapy and good practice recommendations. Int J Clin Pract. 2017;71(10):1–10.
11.
ZhaoDLuoSXuWHuJLinSWangN. Efficacy and safety of hyperbaric oxygen therapy used in patients with diabetic foot: a meta-analysis of randomized clinical trials. Clin Ther. 2017;39(10):2088–2094.e2.
12.
HuangETMansouriJMuradMHet al.A clinical practice guideline for the use of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers. Undersea Hyperb Med. 2015;42(3):205–247.
13.
de OliveiraALMooreZ. Treatment of the diabetic foot by offloading: a systematic review. J Wound Care. 2015;24(12):560, 562-570.
14.
KobayashiNHiranoKNakanoMet al.Clinical effect of wound depth in critical limb ischemia with tissue loss after endovascular treatment. J Vasc Surg. 2015;62(6):1564–1574.
15.
MillsJLSrConteMSArmstrongDGet al.The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on Wound, Ischemia, and foot Infection (WIfI). J Vasc Surg. 2014;59(1):220–234.e1-2.
16.
SpillerovaKBiancariFLeppaniemiAAlbackASoderstromMVenermoM. Differential impact of bypass surgery and angioplasty on angiosome-targeted infrapopliteal revascularization. Eur J Vasc Endovasc Surg. 2015;49(4):412–419.
17.
VairamonSJBabuMViswanathanV. Oxidative stress markers regulating the healing of foot ulcers in patients with type 2 diabetes. Wounds. 2009;21(10):273–279.
18.
AndersonKHammRL. Factors that impair wound healing. J Am Coll Clin Wound Spec. 2012;4(4):84–91.
19.
HangaardSRasmussenAAlmdalTet al.Standard complication screening information can be used for risk assessment for first time foot ulcer among patients with type 1 and type 2 diabetes. Diabetes Res Clin Pract. 2019;151:177–186.
20.
DhatariyaKKLi Ping Wah-Pun SinEChengJOSet al.The impact of glycaemic variability on wound healing in the diabetic foot - a retrospective study of new ulcers presenting to a specialist multidisciplinary foot clinic. Diabetes Res Clin Pract. 2018;135:23–29.
21.
MohapatraABoitetAMalakOet al.Peroneal bypass versus endovascular peroneal intervention for critical limb ischemia. J Vasc Surg. 2019;69(1):148–155.
22.
AhnJRaspovicKMLiuGTet al.Renal function as a predictor of early transmetatarsal amputation failure [published online ahead of print December 12, 2018]. Foot Ankle Spec. 2018.
23.
DasSKYuanYFLiMQ. Predictors of delayed wound healing after successful isolated below-the-knee endovascular intervention in patients with ischemic foot ulcers. J Vasc Surg. 2018;67(4):1181–1190.
24.
WagnerIJSzpalskiCAllenRJJret al.Obesity impairs wound closure through a vasculogenic mechanism. Wound Repair Regen. 2012;20(4):512–522.
25.
PierpontYNDinhTPSalasREet al.Obesity and surgical wound healing: a current review. ISRN Obes. 2014;2014:638936.
26.
RussellL. The importance of patients’ nutritional status in wound healing. Br J Nurs. 2001;10(6 suppl): S42, S44-S49.
27.
KrischakGDAugatPClaesLKinzlLBeckA. The effects of non-steroidal anti-inflammatory drug application on incisional wound healing in rats. J Wound Care. 2007;16(2):76–78.
28.
SorensenLT. Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy: a systematic review. Ann Surg. 2012;255(6):1069–1079.
29.
RanzerMJChenLDiPietroLA. Fibroblast function and wound breaking strength is impaired by acute ethanol intoxication. Alcohol Clin Exp Res. 2011;35(1):83–90.
30.
ReedGWYoungLBaghIMaierMShishehborMH. Hemodynamic assessment before and after endovascular therapy for critical limb ischemia and association with clinical outcomes. JACC Cardiovasc Interv. 2017;10(23):2451–2457.
31.
DarlingJDMcCallumJCSodenPAet al.Clinical results of single-vessel versus multiple-vessel infrapopliteal intervention. J Vasc Surg. 2016;64(6):1675–1681.
32.
WeledjiEPFokamP. Treatment of the diabetic foot - to amputate or not?BMC Surg. 2014;14:83.
33.
SoderstromMAlbackABiancariFLappalainenKLepantaloMVenermoM. Angiosome-targeted infrapopliteal endovascular revascularization for treatment of diabetic foot ulcers. J Vasc Surg. 2013;57(2):427–435.
34.
ShirakiTIidaOTakaharaMet al.Predictors of delayed wound healing after endovascular therapy of isolated infrapopliteal lesions underlying critical limb ischemia in patients with high prevalence of diabetes mellitus and hemodialysis. Eur J Vasc Endovasc Surg. 2015;49(5):565–573.
35.
SoderstromMAhoPSLepantaloMAlbackA. The influence of the characteristics of ischemic tissue lesions on ulcer healing time after infrainguinal bypass for critical leg ischemia. J Vasc Surg. 2009;49(4):932–937.
36.
ConteMS.Discussion. Open surgical revascularization for wound healing: past performance and future directions; and critical evaluation of endovascular surgery for limb salvage. Plast Reconstr Surg. 2011;127(suppl 1):174S–176S.
37.
LejayAGeorgYTartagliaEet al.Long-term outcomes of direct and indirect below-the-knee open revascularization based on the angiosome concept in diabetic patients with critical limb ischemia. Ann Vasc Surg. 2014;28(4):983–989.
38.
ElbadawyAAliHSalehMHasaballahA. Editor’s choice - a prospective study to evaluate complete wound healing and limb salvage rates after angiosome targeted infrapopliteal balloon angioplasty in patients with critical limb ischaemia. Eur J Vasc Endovasc Surg. 2018;55(3):392–397.
39.
AzumaNUchidaHKokuboTKoyaAAkasakaNSasajimaT. Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery?Eur J Vasc Endovasc Surg. 2012;43(3):322–328.
40.
SpillerovaKSettembreNBiancariFAlbackAVenermoM. Angiosome targeted PTA is more important in endovascular revascularisation than in surgical revascularisation: analysis of 545 patients with ischaemic tissue lesions. Eur J Vasc Endovasc Surg. 2017;53(4):567–575.
41.
TreimanGSOderichGSAshrafiASchneiderPA. Management of ischemic heel ulceration and gangrene: an evaluation of factors associated with successful healing. J Vasc Surg. 2000;31(6):1110–1118.
42.
OkazakiJMatsudaDTanakaKet al.Analysis of wound healing time and wound-free period as outcomes after surgical and endovascular revascularization for critical lower limb ischemia. J Vasc Surg. 2018;67(3):817–825.
43.
KretMRChengDAzarbalAFet al.Utility of direct angiosome revascularization and runoff scores in predicting outcomes in patients undergoing revascularization for critical limb ischemia. J Vasc Surg. 2014;59(1):121–128.
44.
NevilleRFAttingerCEBulanEJDucicIThomassenMSidawyAN. Revascularization of a specific angiosome for limb salvage: does the target artery matter?Ann Vasc Surg. 2009;23(3):367–373.
45.
AtarESiegelYAvrahamiRBartalGBacharGNBelenkyA. Balloon angioplasty of popliteal and crural arteries in elderly with critical chronic limb ischemia. Eur J Radiol. 2005;53(2):287–292.
46.
MlekuschWSchillingerMSabetiSMacaTAhmadiRMinarE. Clinical outcome and prognostic factors for ischaemic ulcers treated with PTA in lower limbs. Eur J Vasc Endovasc Surg. 2002;24(2):176–181.
47.
Brochado NetoFCGonzalezJCinelliMJrAlbersM. Bypass to the genicular arteries for revascularisation of the lower limb. Eur J Vasc Endovasc Surg. 2000;20(6):545–549.
48.
NicoloffADTaylorLMJrMcLaffertyRBMonetaGLPorterJM. Patient recovery after infrainguinal bypass grafting for limb salvage. J Vasc Surg. 1998;27(2):256–263; discussion 64-6.
49.
HannaGPFujiseKKjellgrenOet al.Infrapopliteal transcatheter interventions for limb salvage in diabetic patients: importance of aggressive interventional approach and role of transcutaneous oximetry. J Am Coll Cardiol. 1997;30(3):664–669.
KrishnaSMMoxonJVGolledgeJ. A review of the pathophysiology and potential biomarkers for peripheral artery disease. Int J Mol Sci. 2015;16(5):11294–11322.
52.
PatelSMaheshwariAChandraA. Biomarkers for wound healing and their evaluation. J Wound Care. 2016;25(1):46–55.
53.
FadiniGPAlbieroMMillioniRet al.The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker. Diabetologia. 2014;57(9):1947–1956.
54.
PanXChenGWuPHanCHoJK. Skin perfusion pressure as a predictor of ischemic wound healing potential. Biomed Rep. 2018;8(4):330–334.
55.
YamamotoKKawaharaTAkaiAet al.Increase in skin perfusion pressure predicts amputation-free survival after lower extremity bypass surgery for critical limb ischemia. Vasc Med. 2018;23(3):243–249.
56.
TerasakiHInoueYSuganoNet al.A quantitative method for evaluating local perfusion using indocyanine green fluorescence imaging. Ann Vasc Surg. 2013;27(8):1154–1161.
57.
VenermoMSettembreNAlbackAet al.Pilot assessment of the repeatability of indocyanine green fluorescence imaging and correlation with traditional foot perfusion assessments. Eur J Vasc Endovasc Surg. 2016;52(4):527–533.
58.
SettembreNKauhanenPAlbackASpillerovaKVenermoM. Quality control of the foot revascularization using indocyanine green fluorescence imaging. World J Surg. 2017;41(7):1919–1926.
59.
RotherULangW. Noninvasive measurements of tissue perfusion in critical limb ischemia. Gefasschirurgie. 2018;23(Suppl 1):8–12.
